Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up

SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses

(2021) Andrea Pilotto et al.   CLINICAL INFECTIOUS DISEASES

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

(2021) Chaolin Huang et al.   LANCET

Neurological infection with SARS-CoV-2 — the story so far

(2021) Tom Solomon   Nature Reviews Neurology

EEG Abnormalities are Common in COVID‐19 and are Associated with Outcomes

(2021) Lu Lin et al.   ANNALS OF NEUROLOGY

Long covid: WHO calls on countries to offer patients more rehabilitation

(2021) Jacqui Wise   BMJ-British Medical Journal

Post-acute COVID-19 syndrome

(2021) Ani Nalbandian et al.   NATURE MEDICINE

A multicentre validation study of the diagnostic value of plasma neurofilament light

(2021) Nicholas J. Ashton et al.   Nature Communications

Neurological Manifestations of COVID‐19: A review

(2020) Abigail Whittaker et al.   ACTA NEUROLOGICA SCANDINAVICA

Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome

(2020) Patrick Altmann et al.   Journal of Neuroinflammation

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

(2020) Ling Mao et al.   JAMA Neurology

A minimal common outcome measure set for COVID-19 clinical research

(2020) John C Marshall et al.   LANCET INFECTIOUS DISEASES

Neurological associations of COVID-19

(2020) Mark A Ellul et al.   LANCET NEUROLOGY

Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19

(2020) Nelly Kanberg et al.   NEUROLOGY

Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid

(2020) Johan Virhammar et al.   NEUROLOGY

Growth Differentiation Factor-15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized with COVID-19

(2020) Peder L. Myhre et al.   CIRCULATION

Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical COVID-19

(2020) Aylin Yilmaz et al.   JOURNAL OF INFECTIOUS DISEASES

Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients

(2020) Eric M. Liotta et al.   Annals of Clinical and Translational Neurology

Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019

(2020) Raoul Sutter et al.   ANNALS OF NEUROLOGY

Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease

(2020) Elina Millere et al.   EUROPEAN JOURNAL OF NEUROLOGY

Cognitive impact of COVID-19: looking beyond the short term

(2020) Scott Miners et al.   Alzheimers Research & Therapy

GDF15 mediates the effects of metformin on body weight and energy balance

(2019) Anthony P. Coll et al.   NATURE

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

Fluid biomarkers for mild traumatic brain injury and related conditions

(2016) Henrik Zetterberg et al.   Nature Reviews Neurology

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

(2016) Magnus Gisslén et al.   EBioMedicine

Measurement of the Glial Fibrillary Acidic Protein and Its Breakdown Products GFAP-BDP Biomarker for the Detection of Traumatic Brain Injury Compared to Computed Tomography and Magnetic Resonance Imaging

(2015) Paul J. McMahon et al.   JOURNAL OF NEUROTRAUMA